Magic mushroom compound tested for dual relief of chronic pain and depression

NCT ID NCT06518720

First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This phase 2 trial tests whether a single 25 mg dose of psilocybin, the active ingredient in 'magic mushrooms', combined with supportive therapy, can ease chronic neuropathic pain and treatment-resistant depression in adults. Sixteen participants aged 18 to 65 with both conditions will receive the drug once and be monitored for safety, tolerability, and changes in depression and pain scores. The study aims to see if this approach is feasible and worth testing in larger trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a single 25 mg dose of psilocybin, the active ingredient in 'magic mushrooms', given with supportive therapy
What this could lead to
If it works, this could point toward a new treatment option for people living with both chronic nerve pain and depression that hasn't responded to standard therapies.
What could go wrong
This is a very small, early-stage trial with only 16 participants and no placebo group, so results may not apply broadly. Psilocybin can cause intense psychological effects and is not without risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome Depressive Disorder, Treatment-Resistant

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre for Addiction and Mental Health

    RECRUITING

    Toronto, Ontario, M6J1H4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.